AKTSNasdaq United States
Market cap
$3.730 B
$24.13 +2.94%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
53,403,173
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Aktis Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.